New Search

If you are not happy with the results below please do another search

1 search result for:

1

Surgical Science Launches Simbionix ANGIO Tab Pro – First-to-Market Ultra-Portable Endovascular Simulator

Today, Surgical Science (NYSE: DDD) announced its new Simbionix ANGIO Tab Pro endovascular simulator. The ANGIO Tab Pro is a first-to-market solution designed for step-by-step training of endovascular interventions – including 30 modules from basic skills to advanced and complex endovascular procedures, and more than 250 patient scenarios. The lightweight construction renders the ANGIO Tab Pro to be […]